Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-19-001768
Filing Date
2019-01-28
Accepted
2019-01-28 15:43:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64550
  Complete submission text file 0001567619-19-001768.txt   66692
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32384 | Film No.: 19545365
SIC: 2834 Pharmaceutical Preparations